Preliminary efficacy and safety of Relmacabtagene autoleucel (Carteyva) in adults with relapsed/refractory follicular lymphoma in China: A phase I/II clinical trial

被引：3
作者：
Ying, Zhitao [1 ]
Zou, Dehui [2 ,3 ]
Yang, Haiyan [4 ]
Wu, Jianqiu [5 ]
Guo, Ye [6 ]
Li, Wenyu [7 ]
Liu, Hui [8 ]
Wang, Chris [9 ]
Ma, Laura [9 ]
Yang, Su [9 ]
Zhou, Zisong [9 ]
Qin, Yun [9 ]
Song, Yuqin [1 ]
Zhu, Jun [1 ]
机构：
[1] Peking Univ Canc Hosp & Inst, Dept Lymphoma, Key Lab Carcinogenesis & Translat Res, Minist Educ Beijing, 52 Fucheng Rd, Beijing 100142, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Inst Hematol, Dept Lymphoma & Myeloma, Tianjin, Peoples R China
[3] Chinese Acad Med Sci & Peking Union Med Coll, Blood Dis Hosp, State Key Lab Expt Hematol, Tianjin, Peoples R China
[4] Univ Chinese Acad Sci, Zhejiang Canc Hosp, Chinese Acad Sci, Canc Hosp,Inst Basic Med & Canc IBMC,Dept Lymphom, Hangzhou, Zhejiang, Peoples R China
[5] Nanjing Med Univ, Jiangsu Canc Hosp, Jiangsu Inst Canc Res, Jiangsu Red Cross Canc Ctr,Dept Med Oncol, Nanjing, Peoples R China
[6] Tongji Univ, Shanghai Dongfang Hosp, Dept Oncol, Shanghai, Peoples R China
[7] Guangdong Acad Sci, Guangdong Prov Peoples Hosp, Dept Lymphoma, Guangzhou, Guangdong, Peoples R China
[8] Beijing Hosp, Dept Hematol, Beijing, Peoples R China
[9] JW Therapeut Shanghai Co Ltd, Shanghai, Peoples R China
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2022年 / 97卷 / 12期
关键词：
D O I：
10.1002/ajh.26711
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E436 / E438
页数：3
相关论文
共 50 条
  • [41] Phase 2 Study Evaluating the Efficacy and Safety of Parsaclisib in Patients With Relapsed or Refractory Follicular Lymphoma (CITADEL-203)
    Lynch, Ryan C.
    Paneesha, Shankara
    Avigdor, Abraham
    McKinney, Matthew S.
    Wahlin, Bjorn E.
    Hrom, John S.
    Belada, David
    Canales, Miguel
    Cunningham, David
    Devizzi, Liliana
    Morley, Nicholas
    Zheng, Fred
    DeMarini, Douglas J.
    Jiang, Wei
    Trneny, Marek
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (01) : 11 - 12
  • [42] Real-world experience of commercial relmacabtagene autoleucel (relma-cel) for relapsed/refractory central nervous system lymphoma: a multicenter retrospective analysis of patients in China
    Yu, Wenyan
    Huang, Liang
    Mei, Heng
    Li, Yuhua
    Niu, Ting
    Zou, Dehui
    Liu, Yao
    Zhang, Huilai
    Liu, Peng
    Wu, Jianqiu
    Wang, Zhi
    Li, Hui
    Cai, Qingqing
    Mi, Jian-qing
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (05)
  • [43] Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update
    Dreyling, Martin
    Fowler, Nathan Hale
    Dickinson, Michael
    Martinez-Lopez, Joaquin
    Kolstad, Arne
    Butler, Jason
    Ghosh, Monalisa
    Popplewell, Leslie
    Chavez, Julio C.
    Bachy, Emmanuel
    Kato, Koji
    Harigae, Hideo
    Kersten, Marie Jose
    Andreadis, Charalambos
    Riedell, Peter A.
    Ho, P. Joy
    Perez-Simon, Jose Antonio
    Chen, Andy I.
    Nastoupil, Loretta J.
    von Tresckow, Bastian
    Ferreri, Andres Jose Maria
    Teshima, Takanori
    Patten, Piers E. M.
    Mcguirk, Joseph P.
    Petzer, Andreas L.
    Offner, Fritz
    Viardot, Andreas
    Zinzani, Pier Luigi
    Malladi, Ram
    Paule, Ines
    Zia, Aiesha
    Awasthi, Rakesh
    Han, Xia
    Germano, Davide
    O'Donovan, Darragh
    Ramos, Roberto
    Maier, Harald J.
    Masood, Aisha
    Thieblemont, Catherine
    Schuster, Stephen J.
    BLOOD, 2024, 143 (17) : 1713 - 1725
  • [44] Phase I/II trial of clofarabine in refractory and/or relapsed non-Hodgkin's lymphoma (NHL)
    Nabhan, C.
    Fried, W.
    Galvez, A.
    Venugopal, P.
    Bitran, J. D.
    ANNALS OF ONCOLOGY, 2008, 19 : 243 - 243
  • [45] Updated Experience from Mosunetuzumab in Multiple Relapsed Follicular Lymphoma: Promising Efficacy from a Phase I Trial
    Assouline, Sarit
    Kim, Won Seog
    Sehn, Laurie H.
    Schuster, Stephen J.
    Cheah, Chan Yoon
    Nastoupil, Loretta J.
    Shadman, Mazyar
    Yoon, Sung-Soo
    Matasar, Matthew J.
    Diefenbach, Catherine
    Gregory, Gareth P.
    Bartlett, Nancy L.
    Wei, Michael C.
    Doral, Michelle Y.
    Yin, Shen
    Negricea, Raluca
    Li, Chi-Chung
    Penuel, Elicia
    Huang, Huang
    Budde, L. Elizabeth
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S406 - S407
  • [46] A phase I/II trial of the combination of romidepsin and lenalidomide in patients with relapsed/refractory lymphoma and myeloma: Phase I results.
    Lunning, Matthew Alexander
    Ruan, Jia
    Nair, Sumithra
    Boruchov, Adam M.
    Byrne, Regina
    Gerecitano, John F.
    Hamlin, Paul A.
    Inserra, Beth
    Leonard, John
    Lynch, Peggy
    Matasar, Matthew J.
    Moskowitz, Alison J.
    Moskowitz, Craig
    Myskowski, Patricia L.
    Nolan, Patrick
    Palomba, Maria Lia
    Quefeld, Christiane
    Straus, David J.
    Zelenetz, Andrew David
    Horwitz, Steven M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [47] Phase I/II trial of clofarabine in refractory and/or relapsed non-hodgkin's lymphoma (NHL)
    Nabhan, C.
    Fried, W.
    Galvez, A.
    Venugopal, P.
    Gozun, P.
    Bitran, J. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [48] NIVOLUMAB RE-TREATMENT IN PATIENTS WITH RELAPSED/REFRACTORY HODGKIN LYMPHOMA: SAFETY AND EFFICACY OUTCOMES FROM A PHASE 1 CLINICAL TRIAL
    Ansell, S.
    Armand, P.
    Timmerman, J.
    Shipp, M.
    Mckiver, M. Popa
    Zhu, L.
    Lesokhin, A. M.
    HAEMATOLOGICA, 2016, 101 : 49 - 49
  • [49] Efficacy and Safety of AP0866 in Patients With Refractory or Relapsed Cutaneous T-Cell Lymphoma: A Phase 2 Clinical Trial
    Goldinger, Simone M.
    Bischof, Sharon Gobbi
    Fink-Puches, Regina
    Klemke, Claus-Detlev
    Dreno, Brigitte
    Bagot, Martine
    Dummer, Reinhard
    JAMA DERMATOLOGY, 2016, 152 (07) : 837 - 839
  • [50] Two-year follow-up result of RELIANCE study, a multicenter phase 2 trial of relmacabtagene autoleucel in Chinese patients with relapsed/refractory large B-cell lymphoma.
    Ying, Zhitao
    Song, Yuqin
    Yang, Haiyan
    Guo, Ye
    Li, Wenyu
    Zou, Dehui
    Zhou, Daobin
    Wang, Zhao
    Zhang, Mingzhi
    Wu, Jianqiu
    Liu, Hui
    Wang, Chris
    Yang, Su
    Zhou, Zisong
    Qin, Yun
    Zhu, Jun
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
12345